Brief: Shuttle Pharma Expands Patient Enrollment For Phase 2 Clinical Trial

Shuttle Pharmaceuticals Holdings

26/11/2024 14:01

Nov 26 (Reuters) - Shuttle Pharmaceuticals Holdings Inc
 SHPH.O :
    * SHUTTLE PHARMA EXPANDS PATIENT ENROLLMENT FOR PHASE 2
CLINICAL
TRIAL OF ROPIDOXURIDINE FOR TREATMENT OF PATIENTS WITH
GLIOBLASTOMA AS UVA CANCER CENTER DOSES ITS FIRST PATIENT

Source text:  ID:nGNX5xXB8R 
Further company coverage:  SHPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))